Last reviewed · How we verify
albuterol aerosol by HFA BOI
albuterol aerosol by HFA BOI is a Beta-2 adrenergic receptor agonist Small molecule drug developed by Teva Branded Pharmaceutical Products R&D, Inc.. It is currently in Phase 3 development for Maintenance and relief of bronchospasm in asthma and other chronic lung diseases.
Albuterol works by stimulating the beta-2 receptors in the lungs, causing bronchodilation and relaxation of bronchial smooth muscle.
Albuterol works by stimulating the beta-2 receptors in the lungs, causing bronchodilation and relaxation of bronchial smooth muscle. Used for Maintenance and relief of bronchospasm in asthma and other chronic lung diseases.
At a glance
| Generic name | albuterol aerosol by HFA BOI |
|---|---|
| Sponsor | Teva Branded Pharmaceutical Products R&D, Inc. |
| Drug class | Beta-2 adrenergic receptor agonist |
| Target | beta-2 adrenergic receptor |
| Modality | Small molecule |
| Therapeutic area | Respiratory |
| Phase | Phase 3 |
Mechanism of action
This leads to an increase in airway diameter, making it easier to breathe for individuals with asthma or COPD. Albuterol's mechanism of action is primarily through the beta-2 adrenergic receptor, which is a G protein-coupled receptor.
Approved indications
- Maintenance and relief of bronchospasm in asthma and other chronic lung diseases
Common side effects
- Tremors
- Nervousness
- Headache
- Dizziness
- Palpitations
Key clinical trials
- Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- albuterol aerosol by HFA BOI CI brief — competitive landscape report
- albuterol aerosol by HFA BOI updates RSS · CI watch RSS
- Teva Branded Pharmaceutical Products R&D, Inc. portfolio CI
Frequently asked questions about albuterol aerosol by HFA BOI
What is albuterol aerosol by HFA BOI?
How does albuterol aerosol by HFA BOI work?
What is albuterol aerosol by HFA BOI used for?
Who makes albuterol aerosol by HFA BOI?
What drug class is albuterol aerosol by HFA BOI in?
What development phase is albuterol aerosol by HFA BOI in?
What are the side effects of albuterol aerosol by HFA BOI?
What does albuterol aerosol by HFA BOI target?
Related
- Drug class: All Beta-2 adrenergic receptor agonist drugs
- Target: All drugs targeting beta-2 adrenergic receptor
- Manufacturer: Teva Branded Pharmaceutical Products R&D, Inc. — full pipeline
- Therapeutic area: All drugs in Respiratory
- Indication: Drugs for Maintenance and relief of bronchospasm in asthma and other chronic lung diseases
- Compare: albuterol aerosol by HFA BOI vs similar drugs
- Pricing: albuterol aerosol by HFA BOI cost, discount & access